A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Results - Part A: General results, continued
Diagnosis
Data on diagnosis were available for 335,001 (98%) records from the study period. Of these 96,253 were coded as 'no clinical information available' and another 20,592 were coded as 'other diagnosis'. The 10 most common diagnoses (of 62 diagnostic categories accepted in LabVISE), which make up 201,959 or 90 per cent of the remaining 223,205 records are shown in Table 5.Table 5. The 10 most common diagnoses for which samples were submitted for testing to LabVISE laboratories, 1991 to 2000
Code |
Diagnosis description |
n | % |
---|---|---|---|
59 | Genital disease (including sexually transmitted infections) | 39,860 |
17.9 |
06 | Superficial skin or mucous membrane diseases | 36,677 |
16.4 |
02 | Lower respiratory tract infection | 36,320 |
16.3 |
11 | Respiratory tract infection - unspecified | 23,590 |
10.6 |
07 | Gastrointestinal disease | 23,177 |
10.4 |
01 | Upper respiratory tract infection | 20,781 |
9.3 |
17 | Hepatitis | 7,045 |
3.6 |
29 | Bone/joint disease | 5,541 |
2.5 |
G8 | Malaise - general and/or mild fever | 4,537 |
2.0 |
08 | High fever | 4,431 |
2.0 |
Although samples submitted to LabVISE for investigations of genital (STI) disease make up the largest single category, the combined number of investigations of respiratory disease total 80,691 or 36 per cent of the total. It should be noted that the diagnostic descriptions are very broadly defined and the analysis that follows should be interpreted with caution.
The most frequently reported organisms in samples from patients with the 10 most common diagnoses are shown in Table 6.
Table 6. The 10 most frequently isolated organisms in the 10 most frequently reported clinical diagnoses, LabVISE, 1991 to 2000
Genital diseases (n= 39,860) | Skin/mucous membrane disease (n=36,677) | ||||
---|---|---|---|---|---|
Rank | Virus/organism |
Reports | Rank | Virus/organism |
Reports |
1 |
Chlamydia trachomatis | 18,208 |
1 |
Herpes simplex type 1† | 12,029 |
2 |
Herpes simplex type 2† | 14,257 |
2 |
Herpes simplex type 2† | 8,596 |
3 |
Herpes simplex type 1† | 5,539 |
3 |
Varicella-zoster virus | 7,702 |
4 |
Herpes simplex (not typed)† | 743 |
4 |
Rubella | 1,768 |
5 |
Treponema pallidum | 517 |
5 |
Herpes (not typed) | 1,338 |
6 |
Neisseria gonorrhoeae† | 178 |
6 |
Ross River virus | 1,324 |
7 |
Cytomegalovirus | 89 |
7 |
Measles virus | 1,253 |
8 |
Varicella-zoster virus | 67 |
8 |
Parvovirus | 601 |
9 |
Chlamydia trachomatis A-K | 35 |
9 |
Enterovirus (untyped) | 322 |
10 |
Chlamydia spp. | 35 |
10 |
Epstein-Barr virus | 173 |
Lower respiratory tract infection (n=36,320) | Respiratory tract infection - unspecified (n=23,590) | ||||
Rank | Virus/organism |
Reports | Rank | Virus/organism |
Reports |
1 |
Respiratory syncytial virus | 16,349 |
1 |
Respiratory syncytial virus | 9,202 |
2 |
Mycoplasma pneumoniae | 3,750 |
2 |
Influenza A | 2,259 |
3 |
Influenza A | 3,367 |
3 |
Adenovirus (untyped) | 1,629 |
4 |
Parainfluenza virus type 3 | 2,255 |
4 |
Parainfluenza virus type 3 | 1,455 |
5 |
Rhinovirus | 1,753 |
5 |
Mycoplasma pneumoniae | 1,441 |
6 |
Cytomegalovirus | 1,699 |
6 |
Rhinovirus | 1,303 |
7 |
Adenovirus (untyped) | 1,163 |
7 |
Enterovirus (untyped) | 1,013 |
8 |
Influenza B | 1,093 |
8 |
Cytomegalovirus | 880 |
9 |
Bordetella pertussis | 690 |
9 |
Influenza B | 615 |
10 |
Parainfluenza virus type 1 | 478 |
10 |
Bordetella pertussis | 563 |
Gastrointestinal disease (n=23,177) | Upper respiratory tract infection (n=20,781) | ||||
Rank | Virus/organism |
Reports | Rank | Virus/organism |
Reports |
1 |
Rotavirus | 15,887 |
1 |
Respiratory syncytial virus | 5,358 |
2 |
Adenovirus (untyped) | 3,033 |
2 |
Bordetella pertussis | 2,913 |
3 |
Enterovirus (untyped) | 1,865 |
3 |
Rhinovirus | 1,898 |
4 |
Human calicivirus* | 683 |
4 |
Epstein-Barr virus | 1,720 |
5 |
Adenovirus type 40 | 188 |
5 |
Parainfluenza virus type 3 | 1,336 |
6 |
Cytomegalovirus | 161 |
6 |
Influenza A | 1,225 |
7 |
Adenovirus type 2 | 111 |
7 |
Cytomegalovirus | 988 |
8 |
Poliovirus (untyped) | 87 |
8 |
Adenovirus (untyped) | 919 |
9 |
Adenovirus type 1 | 68 |
9 |
Enterovirus (untyped) | 618 |
10 |
Coronavirus | 59 |
10 |
Parainfluenza virus type 1 | 587 |
Hepatitis (n=7,045) | Bone/joint disease (n=5,541) | ||||
Rank | Virus/organism |
Reports | Rank | Virus/organism |
Reports |
1 |
Hepatitis C† | 2,805 |
1 |
Ross River virus | 4,296 |
2 |
Hepatitis A | 1,890 |
2 |
Barmah Forest virus | 308 |
3 |
Hepatitis B antibody† | 1,832 |
3 |
Parvovirus | 176 |
4 |
Epstein-Barr virus | 124 |
4 |
Rubella | 123 |
5 |
Cytomegalovirus | 124 |
5 |
Streptococcus A | 119 |
6 |
Hepatitis D | 103 |
6 |
Epstein-Barr virus | 72 |
7 |
Coxiella burnetii | 29 |
7 |
Influenza A | 55 |
8 |
Hepatitis B antigen† | 23 |
8 |
Cytomegalovirus | 55 |
9 |
Chlamydia trachomatis | 19 |
9 |
Coxiella burnetii | 49 |
10 |
Hepatitis E | 17 |
10 |
Dengue type 2 | 40 |
Malaise (n=4,537) | High fever (n=4,431) | ||||
Rank | Virus/organism |
Reports | Rank | Virus/organism |
Reports |
1 |
Epstein-Barr virus | 710 |
1 |
Ross River virus | 1,270 |
2 |
Cytomegalovirus | 699 |
2 |
Epstein-Barr virus | 458 |
3 |
Ross River virus | 602 |
3 |
Cytomegalovirus | 380 |
4 |
Coxiella burnetii | 236 |
4 |
Influenza A | 280 |
5 |
Influenza A | 192 |
5 |
Respiratory syncytial virus | 210 |
6 |
Hepatitis C† | 152 |
6 |
Coxiella burnetii | 185 |
7 |
Mycoplasma pneumoniae | 145 |
7 |
Adenovirus (untyped) | 138 |
8 |
Rubella | 143 |
8 |
Mycoplasma pneumoniae | 138 |
9 |
Influenza B | 141 |
9 |
Barmah Forest virus | 127 |
10 |
Barmah Forest virus | 125 |
10 |
Enterovirus (untyped) | 99 |
* Combines Norwalk like virus, small round virus and human calicivirus
† Data collected up to 1996 only.
The ranking of organisms identified in different diagnoses over a 10-year period includes a number of pathogens no longer under surveillance through LabVISE. Among samples submitted with a primary diagnosis of genital disease, herpes simplex viral identifications combined comprise 20,539 (51% of the total), although data on herpesvirus were not included in LabVISE after 1996. Since the late 1970s the prevalence of herpes simplex type 2 (HSV-2) infections increased by 30 per cent in the United States of America (USA) and HSV-2 infects an estimated 86 million people worldwide.6
Among respiratory infections, respiratory syncytial virus was most frequently identified in cases of all kinds of respiratory infection, while rotavirus was the predominant organism identified in cases of gastroenteritis. Cases of hepatitis tested in LabVISE were predominantly hepatitis C, although reporting of this pathogen to the system ceased in 1996.
Specimens processed and methods used
Although data fields for type of specimen and methods used for the diagnosis were no longer required in LabVISE after 1996, many laboratories continued to send these data fields. The 10 most common specimens received by LabVISE and the 10 most common methods used in LabVISE laboratories for the detection of antigens and antibodies are shown in Tables 7, 8 and 9.Table 7. The 10 most common specimens received by LabVISE, 1991 to 2000
Rank |
Specimen |
n | % |
---|---|---|---|
1 | Blood | 80,019 |
25.0 |
2 | Nasopharyngeal swab or aspirate | 54,657 |
17.1 |
3 | Other | 42,937 |
13.4 |
4 | Genital swab | 42,782 |
13.4 |
5 | Serum | 34,039 |
10.6 |
6 | Skin | 25,462 |
8.0 |
7 | Faeces/rectal swab | 23,572 |
7.4 |
8 | Urine | 6,367 |
2.0 |
9 | Eye | 3,457 |
1.1 |
10 | Cerebrospinal fluid | 2,196 |
0.7 |
Table 8. The 10 most common methods used to detect microbial antigens in LabVISE laboratories, 1991 to 2000
Rank |
Antigen description |
n | % |
---|---|---|---|
1 | Immunofluorescence | 69,646 |
29.5 |
2 | Enzyme-linked immunosorbent assay | 38,221 |
16.2 |
3 | Light microscopy | 36,955 |
15.7 |
4 | Immunoenzymatic techniques | 33,138 |
14.0 |
5 | Nucleic acid detection | 18,354 |
7.8 |
6 | Radio-immunoassay | 17,547 |
7.4 |
7 | Electronic microscopy | 8,487 |
3.6 |
8 | Other | 3,862 |
1.6 |
9 | Growth characteristics | 2,935 |
1.2 |
10 | Latex agglutination | 2,899 |
1.2 |
Table 9. The 10 most common methods used to detect antibodies in LabVISE, 1991 to 2000
Rank |
Antibody description |
n | % |
---|---|---|---|
1 | Enzyme-linked immunosorbent assay | 71,611 |
42.3 |
2 | Complement fixation | 31,598 |
18.7 |
3 | Immunofluorescence | 26,001 |
15.3 |
4 | Immunoenzymatic techniques | 15,591 |
9.2 |
5 | Other | 9,165 |
5.4 |
6 | Haemagglutination | 3,230 |
1.9 |
7 | Haemagglutination inhibition | 3,169 |
1.9 |
8 | Slide/tube agglutination | 2,473 |
1.5 |
9 | Radioimmunoassay | 2,308 |
1.4 |
10 | Latex agglutination | 2,156 |
1.3 |
Top of page
Pathogens under surveillance in LabVISE, 1991 to 2000
A complete list of pathogens under surveillance for this report is shown in Appendix 3 and is summarised in Table 10.Table 10. Summary of pathogens under surveillance in LabVISE, 1991 to 2000
Pathogen group |
Specific pathogens |
---|---|
Measles, mumps, rubella | Measles, mumps and rubella viruses |
Hepatitis viruses | Hepatitis A, D and E |
Arboviruses | Ross River virus, Barmah Forest virus, dengue (type 1 to 4), Murray Valley encephalitis virus, Kunjin virus, Japanese encephalitis virus, Kokobera virus, Stratford virus and flavivirus (unspecified) |
Adenovirus | Types 1-17, 19, 21-22, 24, 26-32, 34, 35, 37, 40-47 |
Herpesviruses | Herpesvirus type 6, cytomegalovirus, varicella-zoster virus, Epstein-Barr virus |
Other DNA viruses | Parvovirus, papovavirus, molluscum contagiosum, orf virus, poxvirus |
Picornavirus | Coxsackievirus, echovirus, poliovirus, rhinovirus, enterovirus |
Ortho/paramyxovirus | Influenza, parainfluenza, respiratory syncytial virus |
Other RNA virus | Rotavirus, astrovirus, reovirus (unspecified), calicivirus/Norwalk agent, coronavirus, small virus-like particles |
Other non-viral pathogens | Chlamydia, Mycoplasma, Rickettsia, Streptococcus, Yersinia, Brucella, Bordetella, Legionella, Leptospira, Cryptococcus, Treponema, Entamoeba, Toxoplasma, Echinococcus |
The totals for each year for each pathogen group are shown in Table 11. Figure 3 shows the relative proportions of each pathogen group in the total dataset.
Table 11. Total number of reports to LabVISE, 1991 to 2000, by pathogen group and year and percentage of each year's total
Pathogen group |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Measles, mumps, rubella | n % |
534 2.7 |
1,005 4.0 |
1,856 6.6 |
2,464 8.8 |
957 4.1 |
810 2.9 |
469 1.6 |
196 0.8 |
375 1.4 |
144 0.6 |
8,810 3 |
Hepatitis viruses | n % |
482 2.5 |
417 1.6 |
510 1.8 |
393 1.4 |
455 1.9 |
426 1.5 |
643 2.3 |
392 1.7 |
384 1.5 |
159 0.6 |
4,261 2 |
Arboviruses | n % |
955 5.0 |
2,013 8.0 |
2,744 9.7 |
2,577 9.2 |
1,271 5.4 |
3,570 12.8 |
2,311 8.1 |
872 3.7 |
1,726 6.5 |
1,682 7.1 |
19,721 8 |
Adenovirus | n % |
1,518 7.9 |
1,722 6.9 |
1,885 6.7 |
1,542 5.5 |
1,182 5.0 |
1,382 4.9 |
1,017 3.6 |
1,162 5.0 |
1,309 5.0 |
1,205 5.1 |
13,924 5 |
Herpesviruses | n % |
3,706 19.2 |
4,039 16.1 |
4,059 14.4 |
4,311 15.4 |
4,367 18.5 |
4,589 16.4 |
4,426 15.5 |
3,923 16.9 |
5,090 19.2 |
4,738 20.0 |
43,248 17 |
Other DNA viruses | n % |
67 0.3 |
206 0.8 |
109 0.4 |
121 0.4 |
121 0.5 |
282 1.0 |
310 1.1 |
272 1.2 |
474 1.8 |
414 1.7 |
2,376 1 |
Picornavirus | n % |
1,902 9.9 |
2,341 9.3 |
2,630 9.3 |
2,678 9.5 |
1,885 8.0 |
1,559 5.6 |
1,119 3.9 |
1,190 5.1 |
1,631 6.2 |
1,527 6.4 |
18,462 7 |
Ortho/paramyxovirus | n % |
3,833 19.9 |
5,981 23.8 |
5,432 19.2 |
6,244 22.2 |
6,129 26.0 |
6,992 25.0 |
8,782 30.8 |
8,261 35.5 |
6,238 23.6 |
5,604 23.6 |
63,496 25 |
Other RNA virus | n % |
2,832 14.7 |
2,277 9.1 |
2,090 7.4 |
2,332 8.3 |
1,693 7.2 |
1,582 5.7 |
1,522 5.3 |
1,444 6.2 |
2,322 8.8 |
1,864 7.9 |
19,958 8 |
Other non-viral pathogens | n % |
3,458 17.9 |
5,135 20.4 |
6,904 19.3 |
5,406 24.5 |
5,528 23.4 |
6,798 24.2 |
7,919 27.8 |
5,547 23.1 |
6,928 26.2 |
6,374 27.0 |
59,997 24 |
Figure 3. Laboratory reports to LabVISE, 1991 to 2000, by pathogen group
In the study period, reports of non-viral pathogens increased from 17.9 per cent to 27 per cent of the annual reports to LabVISE. Among viral pathogens, ortho/paramyxoviruses made up on average 25 per cent of the annual reports, herpesviruses 17 per cent and other RNA viruses 8 per cent.
This article was published in Communicable Diseases Intelligence Volume 26, No 3, September 2002
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
CDI Vol 26, No 3, September 2002
LabVISE, 1991 to 2000
- Contents and Abbreviations
- Abstract and Authors
- Introduction and Methods
- Part A: General results
- Part A: General results cont
- Part B: Analysis of data by pathogen
- Discussion
- Appendices
- References
Communicable Diseases Intelligence